All lobbying filings
LMH STRATEGIC SOLUTIONS
Lobbying for ALKERMES, INC. · Biopharmaceutical company
Filing
4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 12, 2026
Income
$90,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
2
Bills named in this filing
1
Lobbying activity
1
Medicare/Medicaid issues. Medicaid drug rebate program. Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. H.R.946 - ORPHAN Cures Act.